The aim of this study was to decipher the possible role of STE20-type kinase MAP4K4 in the regulation of hepatocellular lipotoxicity and susceptibility to NAFLD. The gene discussed is MAP4K4; the disease is metabolic dysfunction-associated steatotic liver disease.